Search

Your search keyword '"Riising, Eva M."' showing total 9 results
Start Over Author "Riising, Eva M." Publication Year Range Last 10 years
9 results on '"Riising, Eva M."'

1. GREM1 is required to maintain cellular heterogeneity in pancreatic cancer

Author

Lan, Linxiang, Evan, Theodore, Li, Huafu, Hussain, Aasia, Ruiz, E. Josue, Zaw Thin, May, Ferreira, Rute M. M., Ps, Hari, Riising, Eva M., Zen, Yoh, Almagro, Jorge, Ng, Kevin W., Soro-Barrio, Pablo, Nelson, Jessica, Koifman, Gabriela, Carvalho, Joana, Nye, Emma L., He, Yulong, Zhang, Changhua, Sadanandam, Anguraj, and Behrens, Axel

Published
2022
Full Text
View/download PDF

2. GREM1 is required to maintain cellular heterogeneity in pancreatic cancer

Author

Lan, Linxiang, Evan, Theodore, Li, Huafu, Hussain, Aasia, Ruiz, E. Josue, Zaw Thin, May, Ferreira, Rute M. M., Ps, Hari, Riising, Eva M., Zen, Yoh, Almagro, Jorge, Ng, Kevin W., Soro-Barrio, Pablo, Nelson, Jessica, Koifman, Gabriela, Carvalho, Joana, Nye, Emma L., He, Yulong, Zhang, Changhua, Sadanandam, Anguraj, and Behrens, Axel

Abstract

Pancreatic ductal adenocarcinoma (PDAC) shows pronounced epithelial and mesenchymal cancer cell populations1–4. Cellular heterogeneity in PDAC is an important feature in disease subtype specification3–5, but how distinct PDAC subpopulations interact, and the molecular mechanisms that underlie PDAC cell fate decisions, are incompletely understood. Here we identify the BMP inhibitor GREM16,7as a key regulator of cellular heterogeneity in pancreatic cancer in human and mouse. Grem1inactivation in established PDAC in mice resulted in a direct conversion of epithelial into mesenchymal PDAC cells within days, suggesting that persistent GREM1 activity is required to maintain the epithelial PDAC subpopulations. By contrast, Grem1overexpression caused an almost complete ‘epithelialization’ of highly mesenchymal PDAC, indicating that high GREM1 activity is sufficient to revert the mesenchymal fate of PDAC cells. Mechanistically, Grem1was highly expressed in mesenchymal PDAC cells and inhibited the expression of the epithelial–mesenchymal transition transcription factors Snai1(also known as Snail) and Snai2(also known as Slug) in the epithelial cell compartment, therefore restricting epithelial–mesenchymal plasticity. Thus, constant suppression of BMP activity is essential to maintain epithelial PDAC cells, indicating that the maintenance of the cellular heterogeneity of pancreatic cancer requires continuous paracrine signalling elicited by a single soluble factor.

Published
2024
Full Text
View/download PDF

3. USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma

Author

Ruiz, E Josue, primary, Pinto-Fernandez, Adan, additional, Turnbull, Andrew P, additional, Lan, Linxiang, additional, Charlton, Thomas M, additional, Scott, Hannah C, additional, Damianou, Andreas, additional, Vere, George, additional, Riising, Eva M, additional, Da Costa, Clive, additional, Krajewski, Wojciech W, additional, Guerin, David, additional, Kearns, Jeffrey D, additional, Ioannidis, Stephanos, additional, Katz, Marie, additional, McKinnon, Crystal, additional, O'Connell, Jonathan, additional, Moncaut, Natalia, additional, Rosewell, Ian, additional, Nye, Emma, additional, Jones, Neil, additional, Heride, Claire, additional, Gersch, Malte, additional, Wu, Min, additional, Dinsmore, Christopher J, additional, Hammonds, Tim R, additional, Kim, Sunkyu, additional, Komander, David, additional, Urbe, Sylvie, additional, Clague, Michael J, additional, Kessler, Benedikt M, additional, and Behrens, Axel, additional

Published
2021
Full Text
View/download PDF

4. Author response: USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma

Author

Ruiz, E Josue, primary, Pinto-Fernandez, Adan, additional, Turnbull, Andrew P, additional, Lan, Linxiang, additional, Charlton, Thomas M, additional, Scott, Hannah C, additional, Damianou, Andreas, additional, Vere, George, additional, Riising, Eva M, additional, Da Costa, Clive, additional, Krajewski, Wojciech W, additional, Guerin, David, additional, Kearns, Jeffrey D, additional, Ioannidis, Stephanos, additional, Katz, Marie, additional, McKinnon, Crystal, additional, O'Connell, Jonathan, additional, Moncaut, Natalia, additional, Rosewell, Ian, additional, Nye, Emma, additional, Jones, Neil, additional, Heride, Claire, additional, Gersch, Malte, additional, Wu, Min, additional, Dinsmore, Christopher J, additional, Hammonds, Tim R, additional, Kim, Sunkyu, additional, Komander, David, additional, Urbe, Sylvie, additional, Clague, Michael J, additional, Kessler, Benedikt M, additional, and Behrens, Axel, additional

Published
2021
Full Text
View/download PDF

5. Verification of CRISPR editing and finding transgenic inserts by Xdrop indirect sequence capture followed by short- and long-read sequencing

Author

Blondal, Thorarinn, primary, Gamba, Cristina, additional, Møller Jagd, Lea, additional, Su, Ling, additional, Demirov, Dimiter, additional, Guo, Shuang, additional, Johnston, Camille M., additional, Riising, Eva M., additional, Wu, Xiaolin, additional, Mikkelsen, Marie J., additional, Szabova, Ludmila, additional, and Mouritzen, Peter, additional

Published
2021
Full Text
View/download PDF

6. USP28 deletion and small molecule inhibition destabilises c-Myc and elicits regression of squamous cell lung carcinoma

Author

Ruiz, E. Josue, primary, Pinto-Fernandez, Adan, additional, Turnbull, Andrew P., additional, Lan, Linxiang, additional, Charlton, Thomas M., additional, Scott, Hannah Claire, additional, Damianou, Andreas, additional, Vere, George, additional, Riising, Eva M., additional, Da Costa, Clive, additional, Krajewski, Wojciech W., additional, Guerin, David, additional, Kearns, Jeffrey, additional, Ioannidis, Stephanos, additional, Katz, Marie, additional, McKinnon, Crystal, additional, O’Connell, Jonathan C., additional, Moncaut, Natalia, additional, Rosewell, Ian, additional, Nye, Emma, additional, Jones, Neil, additional, Heride, Claire, additional, Gersch, Malte, additional, Wu, Min, additional, Dinsmore, Christopher J., additional, Hammonds, Tim R., additional, Kim, Sunkyu, additional, Komander, David, additional, Urbé, Sylvie, additional, Clague, Michael J., additional, Kessler, Benedikt M., additional, and Behrens, Axel, additional

Published
2020
Full Text
View/download PDF

7. Verification of CRISPR editing and finding transgenic inserts by Xdrop™ Indirect sequence capture followed by short- and long- read sequencing

Author

Thorarinn, Blondal, primary, Cristina, Gamba, additional, Møller, Jagd Lea, additional, Ling, Su, additional, Dimiter, Demirov, additional, Shuang, Guo, additional, Johnston, Camille M., additional, Riising, Eva M., additional, Xiaolin, Wu, additional, Mikkelsen, Marie J., additional, Ludmila, Szabova, additional, and Peter, Mouritzen, additional

Published
2020
Full Text
View/download PDF

8. Maintaining cell identity:PRC2-mediated regulation of transcription and cancer

Author

Comet, Itys, Riising, Eva M, Leblanc, Benjamin, Helin, Kristian, Comet, Itys, Riising, Eva M, Leblanc, Benjamin, and Helin, Kristian

Abstract

Enhancer of zeste homologue 2 (EZH2), the catalytic subunit of Polycomb repressive complex 2 (PRC2), has attracted broad research attention in the past few years because of its involvement in the development and maintenance of many types of cancer and the use of specific EZH2 inhibitors in clinical trials. Several observations show that PRC2 can have both oncogenic and tumour-suppressive functions. We propose that these apparently opposing roles of PRC2 in cancer are a consequence of the molecular function of the complex in maintaining, rather than specifying, the transcriptional repression state of its several thousand target genes.

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results